Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Ito, Y; Horie, S; Shindo, Y
   A novel [2+2] photodimerization of N-[(E)-3,4-methylenedioxycinnamoyl]dopamine in the solid state
   ORGANIC LETTERS
   
   Y. Ito et al., "A novel [2+2] photodimerization of N-[(E)-3,4-methylenedioxycinnamoyl]dopamine in the solid state", ORG LETT, 3(15), 2001, pp. 2411-2413
2. Bezard, E; Brotchie, JM; Gross, CE
   Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies
   NATURE REVIEWS NEUROSCIENCE
   
   E. Bezard et al., "Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies", NAT REV NEU, 2(8), 2001, pp. 577-588
3. Gimenez-Llort, L; Ahlbom, E; Dare, E; Vahter, M; Ogren, SO; Ceccatelli, S
   Prenatal exposure to methylmercury changes dopamine-modulated motor activity during early ontogeny: age and gender-dependent effects
   ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
   
   L. Gimenez-Llort et al., "Prenatal exposure to methylmercury changes dopamine-modulated motor activity during early ontogeny: age and gender-dependent effects", ENV TOX PH, 9(3), 2001, pp. 61-70
4. Rybakowski, JK; Borkowska, A; Czerski, PM; Hauser, J
   Dopamine D3 receptor (DRD3) gene polymorphism is associated with the intensity of eye movement disturbances in schizophrenic patients and healthy subjects
   MOLECULAR PSYCHIATRY
   
   J.K. Rybakowski et al., "Dopamine D3 receptor (DRD3) gene polymorphism is associated with the intensity of eye movement disturbances in schizophrenic patients and healthy subjects", MOL PSYCHI, 6(6), 2001, pp. 718-724
5. Govoni, S; Racchi, M; Masoero, E; Zamboni, M; Ferini-Strambi, L
   Extrapyramidal symptoms and antidepressant drugs: neuropharmacological aspects of a frequent interaction in the elderly
   MOLECULAR PSYCHIATRY
   
   S. Govoni et al., "Extrapyramidal symptoms and antidepressant drugs: neuropharmacological aspects of a frequent interaction in the elderly", MOL PSYCHI, 6(2), 2001, pp. 134-142
6. Carvey, PM; McGuire, SO; Ling, ZD
   Neuroprotective effects of D3 dopamine receptor agonists
   PARKINSONISM & RELATED DISORDERS
   
   P.M. Carvey et al., "Neuroprotective effects of D3 dopamine receptor agonists", PARKINS R D, 7(3), 2001, pp. 213-223
7. Guttman, M; Jaskolka, J
   The use of pramipexole in Parkinson's disease: are its actions D-3 mediated?
   PARKINSONISM & RELATED DISORDERS
   
   M. Guttman e J. Jaskolka, "The use of pramipexole in Parkinson's disease: are its actions D-3 mediated?", PARKINS R D, 7(3), 2001, pp. 231-234
8. Amenta, F; Ricci, A; Rossodivita, I; Avola, R; Tayebati, SK
   The dopaminergic system in hypertension
   CLINICAL AND EXPERIMENTAL HYPERTENSION
   
   F. Amenta et al., "The dopaminergic system in hypertension", CLIN EXP HY, 23(1-2), 2001, pp. 15-24
9. Sotnikova, TD; Gainetdinov, RR; Grekhova, TV; Rayevsky, KS
   Effects of intrastriatal infusion of D2 and D3 dopamine receptor preferring antagonists on dopamine release in rat dorsal striatum (in vivo microdialysis study)
   PHARMACOLOGICAL RESEARCH
   
   T.D. Sotnikova et al., "Effects of intrastriatal infusion of D2 and D3 dopamine receptor preferring antagonists on dopamine release in rat dorsal striatum (in vivo microdialysis study)", PHARMAC RES, 43(3), 2001, pp. 283-290
10. Lehmann, T; Hubner, H; Gmeiner, P
    Dopaminergic 7-aminotetrahydroindolizines: Ex-chiral pool synthesis and preferential D3 receptor binding
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    
    T. Lehmann et al., "Dopaminergic 7-aminotetrahydroindolizines: Ex-chiral pool synthesis and preferential D3 receptor binding", BIOORG MED, 11(21), 2001, pp. 2863-2866
11. Dziedzicka-Wasylewska, M; Ferrari, F; Johnson, RD; Mierau, J; Rogoz, Z; Skuza, G; Sokoloff, P
    Mechanisms of action of pramipexole: Effects on receptors
    REVIEWS IN CONTEMPORARY PHARMACOTHERAPY
    
    M. Dziedzicka-Wasylewska et al., "Mechanisms of action of pramipexole: Effects on receptors", REV CONT PH, 12(1-2), 2001, pp. 1-31
12. Betancur, C; Lepee-Lorgeoux, I; Cazillis, M; Accili, D; Fuchs, S; Rostene, W
    Neurotensin gene expression and behavioral responses following administration of psychostimulants and antipsychotic drugs in dopamine D-3 receptor deficient mice
    NEUROPSYCHOPHARMACOLOGY
    
    C. Betancur et al., "Neurotensin gene expression and behavioral responses following administration of psychostimulants and antipsychotic drugs in dopamine D-3 receptor deficient mice", NEUROPSYCH, 24(2), 2001, pp. 170-182
13. Verlinden, L; Verstuyf, A; Quack, M; Van Camp, M; Van Etten, E; De Clercq, P; Vandewalle, M; Carlberg, C; Bouillon, R
    Interaction of two novel 14-epivitamin D-3 analogs with vitamin D-3 receptor-retinoid X receptor heterodimers on vitamin D-3 responsive elements
    JOURNAL OF BONE AND MINERAL RESEARCH
    
    L. Verlinden et al., "Interaction of two novel 14-epivitamin D-3 analogs with vitamin D-3 receptor-retinoid X receptor heterodimers on vitamin D-3 responsive elements", J BONE MIN, 16(4), 2001, pp. 625-638
14. Levant, B; McCarson, KE
    D-3 dopamine receptors in rat spinal cord: implications for sensory and motor function
    NEUROSCIENCE LETTERS
    
    B. Levant e K.E. McCarson, "D-3 dopamine receptors in rat spinal cord: implications for sensory and motor function", NEUROSCI L, 303(1), 2001, pp. 9-12
15. Whitfield, GK; Remus, LS; Jurutka, PW; Zitzer, H; Oza, AK; Dang, HTL; Haussler, CA; Galligan, MA; Thatcher, ML; Dominguez, CE; Haussler, MR
    Functionally relevant polymorphisms in the human nuclear vitamin D receptor gene
    MOLECULAR AND CELLULAR ENDOCRINOLOGY
    
    G.K. Whitfield et al., "Functionally relevant polymorphisms in the human nuclear vitamin D receptor gene", MOL C ENDOC, 177(1-2), 2001, pp. 145-159
16. Liao, DL; Yeh, YC; Chen, HM; Chen, H; Hong, CJ; Tsai, SJ
    Association between the Ser9Gly polymorphism of the dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients
    NEUROPSYCHOBIOLOGY
    
    D.L. Liao et al., "Association between the Ser9Gly polymorphism of the dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients", NEUROPSYCHB, 44(2), 2001, pp. 95-98
17. Hillefors, M; von Euler, G
    Pharmacology of [H-3]R(+)-7-OH-DPAT binding in the rat caudate-putamen
    NEUROCHEMISTRY INTERNATIONAL
    
    M. Hillefors e G. von Euler, "Pharmacology of [H-3]R(+)-7-OH-DPAT binding in the rat caudate-putamen", NEUROCHEM I, 38(1), 2001, pp. 31-42
18. Deransart, C; Landwehrmeyer, GB; Feuerstein, TJ; Lucking, CH
    Up-regulation of D3 dopaminergic receptor mRNA in the core of the nucleus accumbens accompanies the development of seizures in a genetic model of absence-epilepsy in the rat
    MOLECULAR BRAIN RESEARCH
    
    C. Deransart et al., "Up-regulation of D3 dopaminergic receptor mRNA in the core of the nucleus accumbens accompanies the development of seizures in a genetic model of absence-epilepsy in the rat", MOL BRAIN R, 94(1-2), 2001, pp. 166-177
19. Gut-Fayand, A; Dervaux, A; Olie, JP; Loo, H; Poirier, MF; Krebs, MO
    Substance abuse and suicidality in schizophrenia: a common risk factor linked to impulsivity
    PSYCHIATRY RESEARCH
    
    A. Gut-Fayand et al., "Substance abuse and suicidality in schizophrenia: a common risk factor linked to impulsivity", PSYCHIAT R, 102(1), 2001, pp. 65-72
20. Richtand, NM; Woods, SC; Berger, SP; Strakowski, SM
    D3 dopamine receptor, behavioral sensitization, and psychosis
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
    
    N.M. Richtand et al., "D3 dopamine receptor, behavioral sensitization, and psychosis", NEUROSCI B, 25(5), 2001, pp. 427-443
21. Mattingly, BA; Caudill, A; Abel, M
    Differential effects of 7-OH-DPAT on the development of behavioral sensitization to apomorphine and cocaine
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    
    B.A. Mattingly et al., "Differential effects of 7-OH-DPAT on the development of behavioral sensitization to apomorphine and cocaine", PHARM BIO B, 68(3), 2001, pp. 417-426
22. Zuch, CL; Cory-Slechta, DA
    Stimulus properties of 7-OH-DPAT versus auto- and postsynaptic receptor-specific doses of quinpirole
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    
    C.L. Zuch e D.A. Cory-Slechta, "Stimulus properties of 7-OH-DPAT versus auto- and postsynaptic receptor-specific doses of quinpirole", PHARM BIO B, 68(3), 2001, pp. 469-479
23. Blednov, YA; Stoffel, M; Chang, SR; Harris, RA
    GIRK2 deficient mice - Evidence for hyperactivity and reduced anxiety
    PHYSIOLOGY & BEHAVIOR
    
    Y.A. Blednov et al., "GIRK2 deficient mice - Evidence for hyperactivity and reduced anxiety", PHYSL BEHAV, 74(1-2), 2001, pp. 109-117
24. Audinot, V; Newman-Tancredi, A; Millan, MJ
    Constitutive activity at serotonin 5-HT1D receptors: detection by homologous GTP gamma S versus [S-35]-GTP gamma S binding isotherms
    NEUROPHARMACOLOGY
    
    V. Audinot et al., "Constitutive activity at serotonin 5-HT1D receptors: detection by homologous GTP gamma S versus [S-35]-GTP gamma S binding isotherms", NEUROPHARM, 40(1), 2001, pp. 57-64
25. Scarselli, M; Novi, F; Schallmach, E; Ling, RW; Baragli, A; Colzi, A; Griffon, N; Corsini, GU; Sokoloff, P; Levenson, R; Vogel, Z; Maggio, R
    D-2/D-3 dopamine receptor heterodimers exhibit unique functional properties
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    M. Scarselli et al., "D-2/D-3 dopamine receptor heterodimers exhibit unique functional properties", J BIOL CHEM, 276(32), 2001, pp. 30308-30314
26. Walbert, T; Jirikowski, GF; Prufer, K
    Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the limbic system of the rat
    HORMONE AND METABOLIC RESEARCH
    
    T. Walbert et al., "Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the limbic system of the rat", HORMONE MET, 33(9), 2001, pp. 525-531
27. Curran, MP; Perry, CM
    Amisulpride - A review of its use in the management of schizophrenia
    DRUGS
    
    M.P. Curran e C.M. Perry, "Amisulpride - A review of its use in the management of schizophrenia", DRUGS, 61(14), 2001, pp. 2123-2150
28. Horikawa, T; Hirokawa, Y; Kato, S
    A practical preparation of methyl 2-methoxy-6-methylaminopyridine-3-carboxylate from 2,6-dichloro-3-trifluoromethylpyridine
    CHEMICAL & PHARMACEUTICAL BULLETIN
    
    T. Horikawa et al., "A practical preparation of methyl 2-methoxy-6-methylaminopyridine-3-carboxylate from 2,6-dichloro-3-trifluoromethylpyridine", CHEM PHARM, 49(12), 2001, pp. 1621-1627
29. Weber, B; Schlicker, E; Sokoloff, P; Stark, H
    Identification of the dopamine autoreceptor in the guinea-pig retina as D-2 receptor using novel subtype-selective antagonists
    BRITISH JOURNAL OF PHARMACOLOGY
    
    B. Weber et al., "Identification of the dopamine autoreceptor in the guinea-pig retina as D-2 receptor using novel subtype-selective antagonists", BR J PHARM, 133(8), 2001, pp. 1243-1248
30. Yoshikawa, T; Yoshida, N; Oka, M
    The broad-spectrum anti-emetic activity of AS-8112, a novel dopamine D-2, D-3 and 5-HT3 receptors antagonist
    BRITISH JOURNAL OF PHARMACOLOGY
    
    T. Yoshikawa et al., "The broad-spectrum anti-emetic activity of AS-8112, a novel dopamine D-2, D-3 and 5-HT3 receptors antagonist", BR J PHARM, 133(2), 2001, pp. 253-260
31. Wade, TV; Rothblat, DS; Schneider, JS
    Changes in striatal dopamine D3 receptor regulation during expression of and recovery from MPTP-induced parkinsonism
    BRAIN RESEARCH
    
    T.V. Wade et al., "Changes in striatal dopamine D3 receptor regulation during expression of and recovery from MPTP-induced parkinsonism", BRAIN RES, 905(1-2), 2001, pp. 111-119
32. Lopes-Machado, EZ; Duarte, FAM
    Localization of genes modulating the predisposition to schizophrenia: a revision
    GENETICS AND MOLECULAR BIOLOGY
    
    E.Z. Lopes-Machado e F.A.M. Duarte, "Localization of genes modulating the predisposition to schizophrenia: a revision", GENET MOL B, 23(3), 2000, pp. 549-556
33. Ishiguro, H; Okuyama, Y; Toru, M; Arinami, T
    Mutation and association analysis of the 5 ' region of the dopamine D3 receptor gene in schizophrenia patients: identification of the Ala38Thr polymorphism and suggested association between DRD3 haplotypes and schizophrenia
    MOLECULAR PSYCHIATRY
    
    H. Ishiguro et al., "Mutation and association analysis of the 5 ' region of the dopamine D3 receptor gene in schizophrenia patients: identification of the Ala38Thr polymorphism and suggested association between DRD3 haplotypes and schizophrenia", MOL PSYCHI, 5(4), 2000, pp. 433-438
34. 
    Tetrahydroisoquinololine derivatives as modulators of dopamine D-3 receptors
    EXPERT OPINION ON THERAPEUTIC PATENTS
    
    EXPERT OP T, 10(6), 2000, pp. 985-989
35. Hubble, JP
    Pre-clinical studies of pramipexole: clinical relevance
    EUROPEAN JOURNAL OF NEUROLOGY
    
    J.P. Hubble, "Pre-clinical studies of pramipexole: clinical relevance", EUR J NEUR, 7, 2000, pp. 15-20
36. Dutta, AK; Neisewander, J; Fuchs, R; Reith, MEA
    Synthesis and characterization of novel derivatives of 2-aminotetralins: Development of highly selective derivatives for the D3 receptor
    MEDICINAL CHEMISTRY RESEARCH
    
    A.K. Dutta et al., "Synthesis and characterization of novel derivatives of 2-aminotetralins: Development of highly selective derivatives for the D3 receptor", MED CHEM RE, 10(4), 2000, pp. 208-229
37. Swamy, N; Addo, JK; Ray, R
    Development of an affinity-driven cross-linker: Isolation of a vitamin D receptor associated factor
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    
    N. Swamy et al., "Development of an affinity-driven cross-linker: Isolation of a vitamin D receptor associated factor", BIOORG MED, 10(4), 2000, pp. 361-364
38. Einsiedel, J; Thomas, C; Hubner, H; Gmeiner, P
    Phenyloxazoles and phenylthiazoles as benzamide bioisosteres: Synthesis and dopamine receptor binding profiles
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    
    J. Einsiedel et al., "Phenyloxazoles and phenylthiazoles as benzamide bioisosteres: Synthesis and dopamine receptor binding profiles", BIOORG MED, 10(17), 2000, pp. 2041-2044
39. McKenna, NJ; O'Malley, BW
    From ligand to response: generating diversity in nuclear receptor coregulator function
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
    
    N.J. McKenna e B.W. O'Malley, "From ligand to response: generating diversity in nuclear receptor coregulator function", J STEROID B, 74(5), 2000, pp. 351-356
40. Carta, AR; Gerfen, CR; Steiner, H
    Cocaine effects on gene regulation in the striatum and behavior: increasedsensitivity in D3 dopamine receptor-deficient mice
    NEUROREPORT
    
    A.R. Carta et al., "Cocaine effects on gene regulation in the striatum and behavior: increasedsensitivity in D3 dopamine receptor-deficient mice", NEUROREPORT, 11(11), 2000, pp. 2395-2399
41. Joyce, JN; Yoshimoto, K; Ueda, S
    The zitter mutant rat exhibits loss of D3 receptors with degeneration of the dopamine system
    NEUROREPORT
    
    J.N. Joyce et al., "The zitter mutant rat exhibits loss of D3 receptors with degeneration of the dopamine system", NEUROREPORT, 11(10), 2000, pp. 2173-2175
42. Perachon, S; Betancur, C; Pilon, C; Rostene, W; Schwartz, JC; Sokoloff, P
    Role of dopamine D-3 receptors in thermoregulation: a reappraisal
    NEUROREPORT
    
    S. Perachon et al., "Role of dopamine D-3 receptors in thermoregulation: a reappraisal", NEUROREPORT, 11(1), 2000, pp. 221-225
43. Dringenberg, HC; Wightman, M; Beninger, RJ
    The effects of amphetamine and raclopride on food transport: possible relation to defensive behavior in rats
    BEHAVIOURAL PHARMACOLOGY
    
    H.C. Dringenberg et al., "The effects of amphetamine and raclopride on food transport: possible relation to defensive behavior in rats", BEHAV PHARM, 11(6), 2000, pp. 447-454
44. Scatton, B; Sanger, DJ
    Pharmacological and molecular targets in the search for novel antipsychotics
    BEHAVIOURAL PHARMACOLOGY
    
    B. Scatton e D.J. Sanger, "Pharmacological and molecular targets in the search for novel antipsychotics", BEHAV PHARM, 11(3-4), 2000, pp. 243-256
45. Bordet, R; Ridray, S; Schwartz, JC; Sokoloff, P
    Involvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats
    EUROPEAN JOURNAL OF NEUROSCIENCE
    
    R. Bordet et al., "Involvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats", EUR J NEURO, 12(6), 2000, pp. 2117-2123
46. Campbell, MJ; Gombart, AF; Kwok, SH; Park, S; Koeffler, HP
    The anti-proliferative effects of 1 alpha,25(OH)(2)D-3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression
    ONCOGENE
    
    M.J. Campbell et al., "The anti-proliferative effects of 1 alpha,25(OH)(2)D-3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression", ONCOGENE, 19(44), 2000, pp. 5091-5097
47. Petronis, A
    The genes for major psychosis: Aberrant sequence or regulation?
    NEUROPSYCHOPHARMACOLOGY
    
    A. Petronis, "The genes for major psychosis: Aberrant sequence or regulation?", NEUROPSYCH, 23(1), 2000, pp. 1-12
48. Kroncke, KD; Carlberg, C
    Inactivation of zinc finger transcription factors provides a mechanism fora gene regulatory role of nitric oxide
    FASEB JOURNAL
    
    K.D. Kroncke e C. Carlberg, "Inactivation of zinc finger transcription factors provides a mechanism fora gene regulatory role of nitric oxide", FASEB J, 14(1), 2000, pp. 166-173
49. Jurutka, PW; Remus, LS; Whitfield, GK; Thompson, PD; Hsieh, JC; Zitzer, H; Tavakkoli, P; Galligan, MA; Dang, HTL; Haussler, CA; Haussler, MR
    The polymorphic N terminus in human vitamin D receptor isoforms influencestranscriptional activity by modulating interaction with transcription factor IIB
    MOLECULAR ENDOCRINOLOGY
    
    P.W. Jurutka et al., "The polymorphic N terminus in human vitamin D receptor isoforms influencestranscriptional activity by modulating interaction with transcription factor IIB", MOL ENDOCR, 14(3), 2000, pp. 401-420
50. Videbaek, C; Toska, K; Scheideler, MA; Paulson, OB; Knudsen, GM
    SPECT tracer [I-123]IBZM has similar affinity to dopamine D2 and D3 receptors
    SYNAPSE
    
    C. Videbaek et al., "SPECT tracer [I-123]IBZM has similar affinity to dopamine D2 and D3 receptors", SYNAPSE, 38(3), 2000, pp. 338-342
51. Canales, JJ; Iversen, SD
    Dynamic dopamine receptor interactions in the core and shell of nucleus accumbens differentially coordinate the expression of unconditioned motor behaviors
    SYNAPSE
    
    J.J. Canales e S.D. Iversen, "Dynamic dopamine receptor interactions in the core and shell of nucleus accumbens differentially coordinate the expression of unconditioned motor behaviors", SYNAPSE, 36(4), 2000, pp. 297-306
52. Hirsch, EC
    Nigrostriatal system plasticity in Parkinson's disease: Effect of dopaminergic denervation and treatment
    ANNALS OF NEUROLOGY
    
    E.C. Hirsch, "Nigrostriatal system plasticity in Parkinson's disease: Effect of dopaminergic denervation and treatment", ANN NEUROL, 47(4), 2000, pp. S115-S121
53. Langer, O; Gulyas, B; Sandell, J; Laszlovszky, I; Kiss, B; Domany, G; Acs, T; Farde, L; Halldin, C
    Radiochemical labelling of the dopamine D-3 receptor ligand RGH-1756
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    
    O. Langer et al., "Radiochemical labelling of the dopamine D-3 receptor ligand RGH-1756", J LABEL C R, 43(11), 2000, pp. 1069-1074
54. Barbanti, P; Fabbrini, G; Ricci, A; Pascali, MP; Bronzetti, E; Amenta, F; Lenzi, GL; Cerbo, R
    Migraine patients show an increased density of dopamine D3 and D4 receptors on lymphocytes
    CEPHALALGIA
    
    P. Barbanti et al., "Migraine patients show an increased density of dopamine D3 and D4 receptors on lymphocytes", CEPHALALGIA, 20(1), 2000, pp. 15-19
55. Boulay, D; Depoortere, R; Perrault, G; Sanger, DJ
    Decreased locomotor activity after microinjection of dopamine D-2/D-3 receptor agonists and antagonists into lobule 9/10 of the cerebellum: A D-3 receptor mediated effect?
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    
    D. Boulay et al., "Decreased locomotor activity after microinjection of dopamine D-2/D-3 receptor agonists and antagonists into lobule 9/10 of the cerebellum: A D-3 receptor mediated effect?", PROG NEUR-P, 24(1), 2000, pp. 39-49
56. Rachez, C; Gamble, M; Chang, CPB; Atkins, GB; Lazar, MA; Freedman, LP
    The DRIP complex and SRC-1/p160 coactivators share similar nuclear receptor binding determinants but constitute functionally distinct complexes
    MOLECULAR AND CELLULAR BIOLOGY
    
    C. Rachez et al., "The DRIP complex and SRC-1/p160 coactivators share similar nuclear receptor binding determinants but constitute functionally distinct complexes", MOL CELL B, 20(8), 2000, pp. 2718-2726
57. Diaz, J; Pilon, C; Le Foll, B; Gros, C; Triller, A; Schwartz, JC; Sokoloff, P
    Dopamine D-3 receptors expressed by all mesencephalic dopamine neurons
    JOURNAL OF NEUROSCIENCE
    
    J. Diaz et al., "Dopamine D-3 receptors expressed by all mesencephalic dopamine neurons", J NEUROSC, 20(23), 2000, pp. 8677-8684
58. Anton, B; Calva, JC; Valdez, A; Acevedo, R; Morales, A; Medecigo, M; Leff, P
    Neurobiology of addiction: Neuroanatomical, neurochemical, molecular and genetic aspects of morphine and cocaine addiction. Part II
    SALUD MENTAL
    
    B. Anton et al., "Neurobiology of addiction: Neuroanatomical, neurochemical, molecular and genetic aspects of morphine and cocaine addiction. Part II", SALUD MENT, 23(4), 2000, pp. 38-44
59. Ellinwood, EH; King, GR; Davidson, C; Lee, TH
    The dopamine D-2/D-3 antagonist DS121 potentiates the effect of cocaine onlocomotion and reduces tolerance in cocaine tolerant rats
    BEHAVIOURAL BRAIN RESEARCH
    
    E.H. Ellinwood et al., "The dopamine D-2/D-3 antagonist DS121 potentiates the effect of cocaine onlocomotion and reduces tolerance in cocaine tolerant rats", BEH BRA RES, 116(2), 2000, pp. 169-175
60. Kremer, I; Rietschel, M; Dobrusin, M; Mujaheed, M; Murad, I; Blanaru, M; Bannoura, I; Muller, DJ; Schulze, TG; Reshef, A; Gathas, S; Schwab, S; Wildenauer, D; Bachner-Melman, R; Belmaker, RH; Maier, W; Ebstein, RP
    No association between the dopamine D3 receptor Bal I polymorphism and schizophrenia in a family-based study of a Palestinian Arab population
    AMERICAN JOURNAL OF MEDICAL GENETICS
    
    I. Kremer et al., "No association between the dopamine D3 receptor Bal I polymorphism and schizophrenia in a family-based study of a Palestinian Arab population", AM J MED G, 96(6), 2000, pp. 778-780
61. Barr, CL; Wigg, KG; Wu, J; Zai, C; Bloom, S; Tannock, R; Roberts, W; Malone, M; Schachar, R; Kennedy, JL
    Linkage study of two polymorphisms at the dopamine D3 receptor gene and attention-deficit hyperactivity disorder
    AMERICAN JOURNAL OF MEDICAL GENETICS
    
    C.L. Barr et al., "Linkage study of two polymorphisms at the dopamine D3 receptor gene and attention-deficit hyperactivity disorder", AM J MED G, 96(1), 2000, pp. 114-117
62. Shang, YF; Hu, X; DiRenzo, J; Lazar, MA; Brown, M
    Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription
    CELL
    
    Y.F. Shang et al., "Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription", CELL, 103(6), 2000, pp. 843-852
63. Depoortere, R; Perrault, G; Sanger, DJ
    The D-3 antagonist PNU-99194A potentiates the discriminative cue produced by the D-3 agonist 7-OH-DPAT
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    
    R. Depoortere et al., "The D-3 antagonist PNU-99194A potentiates the discriminative cue produced by the D-3 agonist 7-OH-DPAT", PHARM BIO B, 65(1), 2000, pp. 31-34
64. Kaasinen, V; Nagren, K; Hietala, J; Oikonen, V; Vilkman, H; Farde, L; Halldin, C; Rinne, JO
    Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson's disease
    NEUROLOGY
    
    V. Kaasinen et al., "Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson's disease", NEUROLOGY, 54(7), 2000, pp. 1482-1487
65. Gilbert, DL; Sethuraman, G; Sine, L; Peters, S; Salle, FR
    Tourette's syndrome improvement with pergolide in a randomized, double-blind, crossover trial
    NEUROLOGY
    
    D.L. Gilbert et al., "Tourette's syndrome improvement with pergolide in a randomized, double-blind, crossover trial", NEUROLOGY, 54(6), 2000, pp. 1310-1315
66. Gilliland, SL; Alper, RH
    Characterization of dopaminergic compounds at hD(2short), hD(4.2) and hD(4.7) receptors in agonist-stimulated [S-35]GTP gamma S binding assays
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    
    S.L. Gilliland e R.H. Alper, "Characterization of dopaminergic compounds at hD(2short), hD(4.2) and hD(4.7) receptors in agonist-stimulated [S-35]GTP gamma S binding assays", N-S ARCH PH, 361(5), 2000, pp. 498-504
67. Stanwood, GD; Artymyshyn, RP; Kung, MP; Kung, HF; Lucki, I; McGonigle, P
    Quantitative autoradiographic mapping of rat brain dopamine D3 binding with [I-125]7-OH-PIPAT: Evidence for the presence of D3 receptors on dopaminergic and nondopaminergic cell bodies and terminals
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    
    G.D. Stanwood et al., "Quantitative autoradiographic mapping of rat brain dopamine D3 binding with [I-125]7-OH-PIPAT: Evidence for the presence of D3 receptors on dopaminergic and nondopaminergic cell bodies and terminals", J PHARM EXP, 295(3), 2000, pp. 1223-1231
68. Stanwood, GD; Lucki, I; McGonigle, P
    Differential regulation of dopamine D2 and D3 receptors by chronic drug treatments
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    
    G.D. Stanwood et al., "Differential regulation of dopamine D2 and D3 receptors by chronic drug treatments", J PHARM EXP, 295(3), 2000, pp. 1232-1240
69. Millan, MJ; Gobert, A; Newman-Tancredi, A; Lejeune, F; Cussac, D; Rivet, JM; Audinot, V; Dubuffet, T; Lavielle, G
    S33084, a novel, potent, selective, and competitive antagonist at dopamineD-3-receptors: I. Receptorial, electrophysiological and neurochemical profile compared with GR218,231 and L741,626
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    
    M.J. Millan et al., "S33084, a novel, potent, selective, and competitive antagonist at dopamineD-3-receptors: I. Receptorial, electrophysiological and neurochemical profile compared with GR218,231 and L741,626", J PHARM EXP, 293(3), 2000, pp. 1048-1062
70. Millan, MJ; Dekeyne, A; Rivet, JM; Dubuffet, T; Lavielle, G; Brocco, M
    S33084, a novel, potent, selective, and competitive antagonist at dopamineD-3-receptors: II. Functional and behavioral profile compared with GR218,231 and L741,626
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    
    M.J. Millan et al., "S33084, a novel, potent, selective, and competitive antagonist at dopamineD-3-receptors: II. Functional and behavioral profile compared with GR218,231 and L741,626", J PHARM EXP, 293(3), 2000, pp. 1063-1073
71. Quack, M; Carlberg, C
    Ligand-triggered stabilization of vitamin D receptor/retinoid X receptor heterodimer conformations on DR4-type response elements
    JOURNAL OF MOLECULAR BIOLOGY
    
    M. Quack e C. Carlberg, "Ligand-triggered stabilization of vitamin D receptor/retinoid X receptor heterodimer conformations on DR4-type response elements", J MOL BIOL, 296(3), 2000, pp. 743-756
72. Chen, SC; Cui, JF; Nakamura, K; Ribeiro, RCJ; West, BL; Gardner, DG
    Coactivator-vitamin D receptor interactions mediate inhibition of the atrial natriuretic peptide promoter
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    S.C. Chen et al., "Coactivator-vitamin D receptor interactions mediate inhibition of the atrial natriuretic peptide promoter", J BIOL CHEM, 275(20), 2000, pp. 15039-15048
73. Ahonen, MH; Zhuang, YH; Aine, R; Ylikomi, T; Tuohimaa, P
    Androgen receptor and vitamin D receptor in human ovarian cancer: Growth stimulation and inhibition by ligands
    INTERNATIONAL JOURNAL OF CANCER
    
    M.H. Ahonen et al., "Androgen receptor and vitamin D receptor in human ovarian cancer: Growth stimulation and inhibition by ligands", INT J CANC, 86(1), 2000, pp. 40-46
74. von Euler, M; Pham, TM; Hillefors, M; Bjelke, B; Henriksson, B; von Euler, G
    Inhalation of low concentrations of toluene induces persistent effects on a learning retention task, beam-walk performance, and cerebrocortical size in the rat
    EXPERIMENTAL NEUROLOGY
    
    M. von Euler et al., "Inhalation of low concentrations of toluene induces persistent effects on a learning retention task, beam-walk performance, and cerebrocortical size in the rat", EXP NEUROL, 163(1), 2000, pp. 1-8
75. Kawanishi, Y; Tachikawa, H; Suzuki, T
    Pharmacogenomics and schizophrenia
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    Y. Kawanishi et al., "Pharmacogenomics and schizophrenia", EUR J PHARM, 410(2-3), 2000, pp. 227-241
76. Karasinska, JM; George, SR; El-Ghundi, M; Fletcher, PJ; O'Dowd, BF
    Modification of dopamine D-1 receptor knockout phenotype in mice lacking both dopamine D-1 and D-3 receptors
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    J.M. Karasinska et al., "Modification of dopamine D-1 receptor knockout phenotype in mice lacking both dopamine D-1 and D-3 receptors", EUR J PHARM, 399(2-3), 2000, pp. 171-181
77. Cussac, D; Newman-Tancredi, A; Sezgin, L; Millan, MJ
    The novel antagonist, S33084, and CR218,231 interact selectively with cloned and native, rat dopamine D-3 receptors as compared with native, rat dopamine D-2 receptors
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    D. Cussac et al., "The novel antagonist, S33084, and CR218,231 interact selectively with cloned and native, rat dopamine D-3 receptors as compared with native, rat dopamine D-2 receptors", EUR J PHARM, 394(1), 2000, pp. 47-50
78. Heijtz, RD; Ogren, SO; Fuxe, K
    Ontogeny of the motor inhibitory role of dopamine D-3 receptor subtype in rats
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    R.D. Heijtz et al., "Ontogeny of the motor inhibitory role of dopamine D-3 receptor subtype in rats", EUR J PHARM, 392(1-2), 2000, pp. 35-39
79. Boulay, D; Depoortere, R; Oblin, A; Sanger, DJ; Schoemaker, H; Perrault, G
    Haloperidol-induced catalepsy is absent in dopamine D-2 but maintained in dopamine D-3 receptor knock-out mice
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    D. Boulay et al., "Haloperidol-induced catalepsy is absent in dopamine D-2 but maintained in dopamine D-3 receptor knock-out mice", EUR J PHARM, 391(1-2), 2000, pp. 63-73
80. Kaichi, Y; Nonaka, R; Hagino, Y; Watanabe, M
    Dopamine D-3 receptor binding by D-3 agonist 7-OH-DPAT (7-hydroxy-dipropylaminotetralin) and antipsychotic drugs measured ex vivo by quantitative autoradiography
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
    
    Y. Kaichi et al., "Dopamine D-3 receptor binding by D-3 agonist 7-OH-DPAT (7-hydroxy-dipropylaminotetralin) and antipsychotic drugs measured ex vivo by quantitative autoradiography", CAN J PHYSL, 78(1), 2000, pp. 7-11
81. Muhlbauer, B; Kuster, E; Luippold, G
    Dopamine D-3 receptors in the rat kidney: role in physiology and pathophysiology
    ACTA PHYSIOLOGICA SCANDINAVICA
    
    B. Muhlbauer et al., "Dopamine D-3 receptors in the rat kidney: role in physiology and pathophysiology", ACT PHYSL S, 168(1), 2000, pp. 219-223
82. Szumlinski, KK; Goodwill, AM; Szechtman, H
    Locomotor sensitization to quinpirole in rats: effects of drug abstinence and sex
    PSYCHOPHARMACOLOGY
    
    K.K. Szumlinski et al., "Locomotor sensitization to quinpirole in rats: effects of drug abstinence and sex", PSYCHOPHAR, 152(3), 2000, pp. 304-311
83. Cook, CD; Barrett, AC; Syvanthong, C; Picker, MJ
    Modulatory effects of dopamine D3/2 agonists on kappa opioid-induced antinociception and diuresis in the rat
    PSYCHOPHARMACOLOGY
    
    C.D. Cook et al., "Modulatory effects of dopamine D3/2 agonists on kappa opioid-induced antinociception and diuresis in the rat", PSYCHOPHAR, 152(1), 2000, pp. 14-23
84. Cook, CD; Barrett, AC; Syvanthong, C; Picker, MJ
    The dopamine D3/2 agonist 7-OH-DPAT attenuates the development of morphinetolerance but not physical dependence in rats
    PSYCHOPHARMACOLOGY
    
    C.D. Cook et al., "The dopamine D3/2 agonist 7-OH-DPAT attenuates the development of morphinetolerance but not physical dependence in rats", PSYCHOPHAR, 152(1), 2000, pp. 93-104
85. Smith, AD; Smith, DL; Zigmond, MJ; Amalric, M; Koob, GF
    Differential effects of dopamine receptor subtype blockade on performance of rats in a reaction-time paradigm
    PSYCHOPHARMACOLOGY
    
    A.D. Smith et al., "Differential effects of dopamine receptor subtype blockade on performance of rats in a reaction-time paradigm", PSYCHOPHAR, 148(4), 2000, pp. 355-360
86. Kirov, G; Jones, I; McCandless, F; Craddock, N; Owen, MJ
    Family-based association studies of bipolar disorder with candidate genes involved in dopamine neurotransmission: DBH, DAT1, COMT, DRD2, DRD3 and DRD5
    MOLECULAR PSYCHIATRY
    
    G. Kirov et al., "Family-based association studies of bipolar disorder with candidate genes involved in dopamine neurotransmission: DBH, DAT1, COMT, DRD2, DRD3 and DRD5", MOL PSYCHI, 4(6), 1999, pp. 558-565
87. Craig, TA; Benson, LM; Tomlinson, AJ; Veenstra, TD; Naylor, S; Kumar, R
    Analysis of transcription complexes and effects of ligands by microelectrospray ionization mass spectrometry
    NATURE BIOTECHNOLOGY
    
    T.A. Craig et al., "Analysis of transcription complexes and effects of ligands by microelectrospray ionization mass spectrometry", NAT BIOTECH, 17(12), 1999, pp. 1214-1218
88. Zea-Ponce, Y; Laruelle, M
    Protein precipitation: An expedient procedure for the routine analysis of the plasma metabolites of [I-123]IBZM
    NUCLEAR MEDICINE AND BIOLOGY
    
    Y. Zea-Ponce e M. Laruelle, "Protein precipitation: An expedient procedure for the routine analysis of the plasma metabolites of [I-123]IBZM", NUCL MED BI, 26(7), 1999, pp. 811-814
89. Honda, K; Riehl, J; Mignot, E; Nishino, S
    Dopamine D3 agonists into the substantia nigra aggravate cataplexy but do not modify sleep (vol 10, pg 3111, 1999)
    NEUROREPORT
    
    K. Honda et al., "Dopamine D3 agonists into the substantia nigra aggravate cataplexy but do not modify sleep (vol 10, pg 3111, 1999)", NEUROREPORT, 10(17), 1999, pp. 3717-3724
90. Menalled, LB; Dziewczapolski, G; Garcia, MC; Rubinstein, M; Gershanik, OS
    D-3 receptor knockdown through antisense oligonucleotide administration supports its inhibitory role in locomotion
    NEUROREPORT
    
    L.B. Menalled et al., "D-3 receptor knockdown through antisense oligonucleotide administration supports its inhibitory role in locomotion", NEUROREPORT, 10(15), 1999, pp. 3131-3136
91. Honda, K; Riehl, J; Mignot, E; Nishino, S
    Dopamine D-3 agonists into the substratia nigra aggravates cataplexy but does not modify sleep
    NEUROREPORT
    
    K. Honda et al., "Dopamine D-3 agonists into the substratia nigra aggravates cataplexy but does not modify sleep", NEUROREPORT, 10(14), 1999, pp. 3111-3118
92. Scharfetter, J; Chaudhry, HR; Hornik, K; Fuchs, K; Sieghart, W; Kasper, S; Aschauer, HN
    Dopamine D3 receptor gene polymorphism and response to clozapine in schizophrenic Pakistani patients
    EUROPEAN NEUROPSYCHOPHARMACOLOGY
    
    J. Scharfetter et al., "Dopamine D3 receptor gene polymorphism and response to clozapine in schizophrenic Pakistani patients", EUR NEUROPS, 10(1), 1999, pp. 17-20
93. Levant, B; Garimelli, B; Shafer, RA; Merchant, KM
    Increased levels of proneurotensin/neuromedin N mRNA in rat striatum and nucleus accumbens induced by 7-OH-DPAT and nafadotride
    NEUROPSYCHOPHARMACOLOGY
    
    B. Levant et al., "Increased levels of proneurotensin/neuromedin N mRNA in rat striatum and nucleus accumbens induced by 7-OH-DPAT and nafadotride", NEUROPSYCH, 21(2), 1999, pp. 304-311
94. Basile, VS; Masellis, M; Badri, F; Paterson, AD; Meltzer, HY; Lieberman, JA; Potkin, SG; Macciardi, F; Kennedy, JL
    Association of the MscI polymorphism of the dopamine D3 receptor gene withtardive dyskinesia in schizophrenia
    NEUROPSYCHOPHARMACOLOGY
    
    V.S. Basile et al., "Association of the MscI polymorphism of the dopamine D3 receptor gene withtardive dyskinesia in schizophrenia", NEUROPSYCH, 21(1), 1999, pp. 17-27
95. GUREVICH EV; JOYCE JN
    DISTRIBUTION OF DOPAMINE D-3 RECEPTOR-EXPRESSING NEURONS IN THE HUMANFOREBRAIN - COMPARISON WITH D-2 RECEPTOR-EXPRESSING NEURONS
    Neuropsychopharmacology
    
    E.V. Gurevich e J.N. Joyce, "DISTRIBUTION OF DOPAMINE D-3 RECEPTOR-EXPRESSING NEURONS IN THE HUMANFOREBRAIN - COMPARISON WITH D-2 RECEPTOR-EXPRESSING NEURONS", Neuropsychopharmacology, 20(1), 1999, pp. 60-80
96. Prufer, K; Veenstra, TD; Jirikowski, GF; Kumar, R
    Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the rat brain and spinal cord
    JOURNAL OF CHEMICAL NEUROANATOMY
    
    K. Prufer et al., "Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the rat brain and spinal cord", J CHEM NEUR, 16(2), 1999, pp. 135-145
97. Tremblay, M; Rouillard, C; Levesque, D
    Dopamine D-3 receptor antisense administration reduces basal c-fos and NGFI-B mRNA levels in the rat forebrain
    SYNAPSE
    
    M. Tremblay et al., "Dopamine D-3 receptor antisense administration reduces basal c-fos and NGFI-B mRNA levels in the rat forebrain", SYNAPSE, 32(1), 1999, pp. 51-57
98. Xu, M; Koeltzow, TE; Cooper, DC; Tonegawa, S; White, FJ
    Dopamine D3 receptor mutant and wild-type mice exhibit identical responsesto putative D3 receptor-selective agonists and antagonists
    SYNAPSE
    
    M. Xu et al., "Dopamine D3 receptor mutant and wild-type mice exhibit identical responsesto putative D3 receptor-selective agonists and antagonists", SYNAPSE, 31(3), 1999, pp. 210-215
99. Ukai, M; Tamoto, H; Tanaka, T; Kameyama, T
    Characterization of the dopamine D-3 receptor agonist R(+)-7-hydroxy-N, N-di-n-propyl-2-aminotetralin-induced hypo- and hypermotility in mice
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    
    M. Ukai et al., "Characterization of the dopamine D-3 receptor agonist R(+)-7-hydroxy-N, N-di-n-propyl-2-aminotetralin-induced hypo- and hypermotility in mice", HUM PSYCHOP, 14(7), 1999, pp. 453-458
100. Toell, A; Degenhardt, S; Grabensee, B; Carlberg, C
     Inhibitory effect of uremic solutions on protein-DNA-complex formation of the vitamin D receptor and other members of the nuclear receptor superfamily
     JOURNAL OF CELLULAR BIOCHEMISTRY
     
     A. Toell et al., "Inhibitory effect of uremic solutions on protein-DNA-complex formation of the vitamin D receptor and other members of the nuclear receptor superfamily", J CELL BIOC, 74(3), 1999, pp. 386-394